|
|
This screen finds stocks with a 13-week Relative Strength above 70, meaning their price gain over the last 13 weeks ranks in the top 30% of all stocks on the same exchange, which marks them as stocks clearly beating most of the market. Relative Strength is a percentile ranking: a reading of 70 means the stock outperformed 70% of its peers. This is a quarterly ranking that identifies intermediate-term leaders, a common focus of momentum strategies. Do not confuse it with the RSI oscillator.
|
|
|
| Symbol | Name | Industry | Sector | 1-Week Relative Strength | 2-Week Relative Strength | 4-Week Relative Strength | 13-Week Relative Strength | 26-Week Relative Strength | 52-Week Relative Strength | Last | Volume |
| |
| Drug Manufacturers - General | Healthcare | 86 /100 | 63 /100 | 33 /100 | 84 /100 | 89 /100 | 90 /100 | 263.81 |
5,308,118 |
| |
| Drug Manufacturers - General | Healthcare | 73 /100 | 92 /100 | 88 /100 | 89 /100 | 97 /100 | 94 /100 | 1,273.46 |
2,266,275 |
| |
| Drug Manufacturers - General | Healthcare | 37 /100 | 51 /100 | 37 /100 | 93 /100 | 94 /100 | 96 /100 | 145.27 |
8,377,849 |
| |
| Diagnostics & Research | Healthcare | 11 /100 | 10 /100 | 9 /100 | 92 /100 | 15 /100 | 76 /100 | 11.82 |
51,515 |
| |
| Diagnostics & Research | Healthcare | 15 /100 | 19 /100 | 21 /100 | 98 /100 | 99 /100 | 22 /100 | 7.27 |
222,762 |
| |
| Diagnostics & Research | Healthcare | 8 /100 | 14 /100 | 13 /100 | 84 /100 | 98 /100 | 99 /100 | 21.18 |
139,273 |
| |
| Diagnostics & Research | Healthcare | 84 /100 | 39 /100 | 37 /100 | 96 /100 | 93 /100 | 89 /100 | 33.08 |
202,877 |
| |
| Diagnostics & Research | Healthcare | 75 /100 | 29 /100 | 36 /100 | 76 /100 | 90 /100 | 33 /100 | 20.10 |
239,565 |
| |
| Diagnostics & Research | Healthcare | 91 /100 | 98 /100 | 60 /100 | 96 /100 | 93 /100 | 62 /100 | 1.63 |
1,800,258 |
| |
| Diagnostics & Research | Healthcare | 74 /100 | 55 /100 | 42 /100 | 92 /100 | 99 /100 | 96 /100 | 15.85 |
1,115,838 |
| |
| Diagnostics & Research | Healthcare | 90 /100 | 40 /100 | 25 /100 | 91 /100 | 97 /100 | 93 /100 | 25.51 |
1,859,805 |
| |
| Diagnostics & Research | Healthcare | 93 /100 | 94 /100 | 94 /100 | 99 /100 | 100 /100 | 100 /100 | 69.21 |
731,921 |
| |
| Diagnostics & Research | Healthcare | 96 /100 | 34 /100 | 89 /100 | 99 /100 | 99 /100 | 93 /100 | 132.55 |
574,959 |
| |
| Diagnostics & Research | Healthcare | 44 /100 | 77 /100 | 23 /100 | 91 /100 | 98 /100 | 94 /100 | 16.59 |
1,430,722 |
| |
| Diagnostics & Research | Healthcare | 80 /100 | 56 /100 | 54 /100 | 90 /100 | 90 /100 | 34 /100 | 70.34 |
403,470 |
| |
| Diagnostics & Research | Healthcare | 73 /100 | 68 /100 | 51 /100 | 80 /100 | 87 /100 | 63 /100 | 18.10 |
1,691,423 |
| |
| Diagnostics & Research | Healthcare | 50 /100 | 68 /100 | 57 /100 | 97 /100 | 97 /100 | 77 /100 | 173.07 |
1,760,398 |
| |
| Diagnostics & Research | Healthcare | 99 /100 | 97 /100 | 97 /100 | 99 /100 | 100 /100 | 97 /100 | 345.37 |
808,322 |
| |
| Diagnostics & Research | Healthcare | 85 /100 | 84 /100 | 75 /100 | 92 /100 | 92 /100 | 89 /100 | 241.89 |
933,364 |
| |
| Diagnostics & Research | Healthcare | 63 /100 | 84 /100 | 77 /100 | 91 /100 | 94 /100 | 49 /100 | 230.50 |
3,935,841 |
| |
| Diagnostics & Research | Healthcare | 91 /100 | 74 /100 | 43 /100 | 89 /100 | 98 /100 | 98 /100 | 169.08 |
1,661,448 |
| |
| Diagnostics & Research | Healthcare | 94 /100 | 96 /100 | 90 /100 | 88 /100 | 97 /100 | 42 /100 | 185.27 |
1,017,948 |
| |
| Diagnostics & Research | Healthcare | 82 /100 | 42 /100 | 53 /100 | 97 /100 | 98 /100 | 99 /100 | 269.42 |
1,262,688 |
| |
| Diagnostics & Research | Healthcare | 91 /100 | 91 /100 | 69 /100 | 98 /100 | 99 /100 | 85 /100 | 279.36 |
981,196 |
| 3401 matches |
|
|
Data as of Oct 23, 2026, updated intraday
|
|
|
|
| |